Background: Multiple Myeloma (MM) is a neoplasm of B cell lineage characterized by excessive proliferation of abnormal plasma cells, secreting abnormal immunoglobulin causing monoclonal gammopathy which can be detected by the presence of M protein in serum and urine electrophoresis.
Introduction:
The Multiple Myeloma (MM) is a progressive B cell haematological malignancy characterized by unregulated and clonal proliferation of plasma cells of the bone marrow (BM),which produce and secrete anomalous monoclonal immunoglobulin or fragments of those (free light chain or Bence Jones Protein), called M-protein, Myeloma protein or paraprotein, which are secreted into blood and /or urine¹ , ². In haematological neoplasm, MM is the disease with relatively bad prognosis and lower survival rates, 5 years in 15%-20% of cases³.
International Center of Cancer registry have reported an increase in incidence rates and mortality caused by MM in recent decades although it is not yet clear whether this is due to the new means of diagnosis or an actual increase in new cases of the disease³.
The presentation of MM can range from asymptomatic to severely symptomatic,which includes back pain,renal failure, pathologic fracture, recurrent infections, weakness and bleedingt .
The diagnosis of MM depends on identification of monoclonal plasma cells in the BM, M-protein in the serum and/ urine and evidence of lytic bone lesionsu . The use of efficient and accurate technique for diagnosis is essential to differentiate other forms monoclonal gammopathyv.
Currently, Serum Protein Electrophoresis (SPEP) remains the standard technique for the diagnosis of patients with MMw . Although capillary protein electrophoresisis considered a relatively simple laboratory method for the detection of M-protein, but Serum Immunofixation Electrophoresis (IFE) technique is now considered a gold standard for confirming the presence of these protein and to distinguish light and heavy chain in MMx . Present study is aimed to detect and quantify monoclonal gamma globulins by SPEP in suspected case of MM and other plasma cell dyscrasia and also to find out the discrepant findings between SPEP and IFE.
Materials and Methods:
This retrospective observational study was carried out at Armed Forces Institute of Pathology (AFIP), Dhaka Cantonment from January 2015 to July 2016. A total of 140 blood samples were collected from clinically suspected cases of MM and other plasma cell dyscrasia and subjected to SPEP and IFE in the department of haematology, AFIP. Protein electrophoresis of the samples was performed by automated capillary electrophoresis machine, Capiflex 2 which identifies the various protein bands and depicts as a graph. The M band is usually found in the gamma globulin region but in a few cases it is identified in the beta region also. The machine identifies the M protein both qualitatively and quantitatively.
Immuno fixation electrophoresis (IFE) was also performed by the same capillary electrophoresis machine Capiflex 2. IFE identifies the type of heavy (IgG, IgM or IgA) and light chain (either kappa [κ] or lambda[λ) in suspected cases of MM and other plasma cell dyscrasia.
Results:
A total of 140 clinically suspected cases of MM and other plasma cell dyscrasia were included in this study during the period from January 2015 to July 2016.
Initially, SPEP were performed on all samples. Sixty two cases were detected as monoclonal gammopathy and remaining 78 cases showed either non-specific findings or polyclonal gammopathy. Among 62 cases, 46 (74.2%) were male and 16(25.8%) were female. The male to female ratio was 2.9:1. Majority of the patients belonged to the age group of 61 to 70 years. Demographic data are shown in Table I . Table II shows the pattern of protein electrophoresis by capillary SPEP in 140 cases. In this study, out of 140 suspected cases of multiple myeloma, 44.3%(62 cases) were found to have monoclonal gammopathy, whereas Chopra at al, found 24.4% sample positive for the M-protein by SPEP¹², Giti Set al reported 6.3% samples¹³ and Delwar at al reported 9.2% samples had monoclonal gammopathy in their studies ¹t , Tripathy Sreported 16 cases (10.7%) of multiple myeloma in her study ¹u . The high percentage of getting monoclonal gammopathy in this study may be explained by taking samples that are highly suspected clinically to have MM as well as small sample size. Low percentage of finding monoclonal band in Giti et al' study was probably due to random selection of samples and large sample size (442).
The analysis of medical records of 62 patients with confirmed diagnosis of MM in our study indicated that the mean age was 63 years, ranging from 61-70 years. This finding correlates most of the published articles 13, 14, 15 ,¹v .
Among 62 M band positive cases, M-spike was observed in the gamma region in 46 (74.2%) cases and 16 cases (25.8%) had it in beta region. This finding is similar to the study carried out by Giti S et al ¹³, but differs from Chopra's study where 84.8% of the cases had the M band in gamma region and 15.2% cases in beta globulin region ¹². This slight difference may be due to the inclusion of large number of case in Chopra's study. 
Conclusion:
The present study showed that there is some limitation in detecting monoclonal band by SPEP. IFE is more sensitive to detect the monoclonal band than SPEP, therefore for diagnosing MM and related disorders, both SPEP and IFE or only IFE should be done to have a definitive result.
